Martinez-Gomez, C.; Michelas, M.; Scarlata, C.-M.; Salvioni, A.; Gomez-Roca, C.; Sarradin, V.; Lauzéral-Vizcaino, F.; Féliu, V.; Dupret-Bories, A.; Ferron, G.;
et al. Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade. Cancers 2022, 14, 3679.
https://doi.org/10.3390/cancers14153679
AMA Style
Martinez-Gomez C, Michelas M, Scarlata C-M, Salvioni A, Gomez-Roca C, Sarradin V, Lauzéral-Vizcaino F, Féliu V, Dupret-Bories A, Ferron G,
et al. Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade. Cancers. 2022; 14(15):3679.
https://doi.org/10.3390/cancers14153679
Chicago/Turabian Style
Martinez-Gomez, Carlos, Marie Michelas, Clara-Maria Scarlata, Anna Salvioni, Carlos Gomez-Roca, Victor Sarradin, Françoise Lauzéral-Vizcaino, Virginie Féliu, Agnès Dupret-Bories, Gwénaël Ferron,
and et al. 2022. "Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade" Cancers 14, no. 15: 3679.
https://doi.org/10.3390/cancers14153679
APA Style
Martinez-Gomez, C., Michelas, M., Scarlata, C.-M., Salvioni, A., Gomez-Roca, C., Sarradin, V., Lauzéral-Vizcaino, F., Féliu, V., Dupret-Bories, A., Ferron, G., Sarini, J., Devaud, C., Delord, J.-P., Balança, C.-C., Martinez, A., & Ayyoub, M.
(2022). Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade. Cancers, 14(15), 3679.
https://doi.org/10.3390/cancers14153679